Tunçtan B, Altuğ S, Uludağ O, Abacioğlu N
Department of Pharmacology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Life Sci. 2000 Sep 29;67(19):2393-401. doi: 10.1016/s0024-3205(00)00822-5.
In our previous study, econazole caused a decrease in serum nitrite levels in septic mice in vivo, but it enhanced the mortality rate. The aim of the study was to investigate the in vitro effects of econazole on receptor-operated and depolarization-induced contractions on endothelium-intact and -denuded rat isolated aorta. Econazole (0.1, 1 and 10 microM) significantly inhibited receptor-operated (phenylephrine, Phe) and depolarization (KCl)-induced contractions of endothelium-intact or -denuded rings in a noncompetitive and concentration-dependent manner. Removal of endothelium changed the pD'2 values only for KCl-induced responses. The pD'2 values of L-type calcium channel blocker nifedipine were significantly higher than the econazole on Phe concentration-response curves in endothelium-intact and -denuded rings. Econazole caused a biphasic response in precontracted by Phe or KCl in endothelium-intact and -denuded rings, first a transient contraction following sustained relaxation. Removal of endothelium did not affect the contractile responses induced by Phe. The contractile responses induced by 10 microM econazole in the KCl-precontracted rings were antagonized by the treatment of alpha-adrenergic receptor antagonist, phentolamine (10 microM). Deendothelization was significantly increased the IC50 values of econazole obtained from Phe- and KCl-precontractions. The relaxations induced by 10 microM econazole in endothelium-intact rings precontracted with Phe or KCl were not changed by NO synthase inhibitor, L-N(G)-nitroarginine (100 microM). The IC50 values of econazole were significantly higher than nifedipine in endothelium-intact and -denuded rings. These results suggest that econazole is a noncompetitive antagonist on alpha1-adrenoceptor-mediated and depolarization-induced contractions in rat isolated aorta by inhibiting Ca2+ entry through L-type calcium channels, and the endothelium seems to modulate vascular responses induced by this agent. The vascular effects of econazole may limit the usage of this agent in septic shock.
在我们之前的研究中,益康唑可使脓毒症小鼠体内的血清亚硝酸盐水平降低,但会提高死亡率。本研究的目的是探讨益康唑对完整内皮和去内皮大鼠离体主动脉上受体介导及去极化诱导收缩的体外作用。益康唑(0.1、1和10微摩尔)以非竞争性和浓度依赖性方式显著抑制完整内皮或去内皮血管环上受体介导(去氧肾上腺素,Phe)及去极化(氯化钾)诱导的收缩。去除内皮仅改变氯化钾诱导反应的pD'2值。在完整内皮和去内皮血管环的去氧肾上腺素浓度-反应曲线上,L型钙通道阻滞剂硝苯地平的pD'2值显著高于益康唑。益康唑在完整内皮和去内皮血管环中对由去氧肾上腺素或氯化钾预收缩的血管产生双相反应,先是短暂收缩,随后是持续舒张。去除内皮不影响去氧肾上腺素诱导的收缩反应。10微摩尔益康唑在氯化钾预收缩血管环中诱导的收缩反应可被α-肾上腺素能受体拮抗剂酚妥拉明(10微摩尔)拮抗。去内皮显著增加了从去氧肾上腺素和氯化钾预收缩中获得的益康唑的半数抑制浓度(IC50)值。10微摩尔益康唑在由去氧肾上腺素或氯化钾预收缩的完整内皮血管环中诱导的舒张不受一氧化氮合酶抑制剂L-N(G)-硝基精氨酸(100微摩尔)的影响。在完整内皮和去内皮血管环中,益康唑的IC50值显著高于硝苯地平。这些结果表明,益康唑通过抑制Ca2+经L型钙通道内流,对大鼠离体主动脉上α1-肾上腺素能受体介导及去极化诱导的收缩起非竞争性拮抗作用,并且内皮似乎可调节该药物诱导的血管反应。益康唑的血管效应可能会限制该药物在脓毒症休克中的应用。